Effect of age at onset and parental disease status on sibling risks for MS

Neurology

Volumn 50, Issue 3, 1998, Pages 719-723

  Sadovnick, A Dessa ^a,c   Yee, Irene M L ^a   Ebers, George C ^d   Risch, Neil J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; DISEASE PREDISPOSITION; FEMALE; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

EID: 0031953328     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.3.719     Document Type: Article

References (18)

1. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based twin study in multiple sclerosis. N Engl J Med 1986; 315:1638-1642.
2. Sadovnick AD, Armstrong H, Rice GPA, et al. A population-based twin study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-285.
3. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
4. Ebers GC, Sadovnick AD, Risch NJ, Canadian Collaborative Study Group. Familial aggregation in multiple sclerosis is genetic. Nature 1995;377:150-151.
5. Sadovnick AD, Ebers GC, Dyment D, Risch NJ, Canadian Collaborative Study Group. Evidence for the genetic basis of multiple sclerosis. Lancet 1996;347:1728-1730.
6. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533-541.
7. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DAS. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996;119:449-455.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Bulman DE, Sadovnick AD, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain 1991;114:937-950.
10. Mackay RP, Myrianthopoulos NC. Multiple sclerosis in twins and their relatives. Final report. Arch Neurol Psychol 1966; 15:449-462.
11. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-568.
12. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Lawless JF. Statistical models and methods for lifetime data. New York: Wiley, 1982:343-400.
14. Sadovnick AD, Bulman D, Ebers GC. Parent child concordance in multiple sclerosis. Ann Neurol 1991;29:252-255.
15. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996;77:2318-2324.
16. Ebers GC, Kukay K, Bulman DE, et al. A full genome screen in multiple sclerosis. Nat Genet 1996;13:472-476.
17. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468.
18. Multiple Sclerosis Genetics Group. Complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996;13:469-471.